ESMO-TAT-2020-1000x250

The 18th edition of the International Congress on Targeted Anticancer Therapies (TAT) will take place in Paris, 2-4 March 2020.

View the online programme

Accreditation

ESMO-MORA: The TAT 2020 programme has been accredited with 24 cat.1 ESMO-MORA points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details.

Webcasts

The congress webcasts will include all the sessions of the official programme, where speaker permission is granted, and will be available on this website and on OncologyPRO for ESMO members.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings